A novel bifunctional protein TNFR2-Fc-IL-1ra (TFI): expression, purification and its neutralization activity of inflammatory factors.

Molecular Biotechnology
Bo XieMizhou M Hui

Abstract

Tumor necrosis factor receptor (TNF) and internleukin-1 (IL-1) are the most potent proinflammatory cytokines involving in autoimmune and inflammatory human diseases. Many anti-inflammatory agents have been exploited for anti-inflammation treatments by targeting cytokines including TNF and IL-1. Theoretically, simultaneously neutralizing or blocking two important inflammatory mediators may achieve a synergistic therapeutic effect. We have developed a recombinant fusion protein, TNFR2-Fc-IL-1ra (TFI), which consists of a TNF-neutralizing domain that specifically binds to TNF-α, an IL-1 receptor antagonist domain, and a dimerization Fc portion of human IgG1, for bifunctional inflammatory inhibitor. Recombinant DNA expressing the sequence of this fusion protein was expressed in CHO-S cells. The protein product was purified using a two-step purification protocol and the identity of the protein was confirmed by western blot analysis. The purified recombinant protein had a purity of about 98 % as determined by HPLC, and a molecular mass of 164.6 kDa as determined by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. The results of cell binding inhibition indicate that TFI was able to strongly neutralize TNF ...Continue Reading

References

Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·B Bresnihan
Jan 18, 2002·Annals of the Rheumatic Diseases·A KaulA S M Jawad
Feb 8, 2006·Cytokine·John B MeeRichard W Groves
Jul 11, 2006·Advanced Drug Delivery Reviews·John R Birch, Andrew J Racher
Nov 14, 2006·FEBS Letters·Stephane PerrierEric Hajduch
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Feb 20, 2008·FEBS Letters·Rachael M DewberrySheila E Francis
Jun 19, 2008·Journal of Bioscience and Bioengineering·Kenji KyogokuShinji Iijima
Nov 6, 2009·Current Opinion in Biotechnology·Yves Durocher, Michael Butler
Jan 23, 2010·Applied Microbiology and Biotechnology·Regine EiblDieter Eibl
Feb 23, 2010·Current Directions in Autoimmunity·Maria ApostolakiGeorge Kollias
Feb 24, 2010·Nature Reviews. Rheumatology·Cem GabayGaby Palmer
Sep 3, 2010·Nature Reviews. Rheumatology·Clare A Notley, Michael R Ehrenstein
Jan 13, 2011·Current Pharmaceutical Design·Ashley M Miller, Iain B McInnes
Mar 16, 2011·Clinical and Experimental Immunology·D S Vinay, B S Kwon
May 3, 2011·Gastroenterology·Warren Strober, Ivan J Fuss
Aug 2, 2011·Trends in Molecular Medicine·Jagadeesh Bayry

❮ Previous
Next ❯

Citations

Nov 2, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Zhonglin LiuJames M Woolfenden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here